Free Trial

Sean Wieland Analyst Performance

Analyst at Piper Sandler

Sean Wieland is a stock analyst at Piper Sandler, covering 20 publicly traded companies across a range of sectors. Over the past year, Sean Wieland has issued 3 stock ratings, including and buy recommendations. While full access to Sean Wieland's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Sean Wieland's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
66 Last 10 Years
Buy Recommendations
76.19% 48 Buy Ratings
Companies Covered
20 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy76.2%48 ratings
Hold19.0%12 ratings
Sell4.8%3 ratings

Out of 63 total stock ratings issued by Sean Wieland at Piper Sandler, the majority (76.2%) have been Buy recommendations, followed by 19.0% Hold and 4.8% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
65.0% of companies on NASDAQ
13 companies
NYSE
35.0% of companies on NYSE
7 companies

Sean Wieland, an analyst at Piper Sandler, currently covers 20 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
12 companies
60.0%
Computer and Technology
4 companies
20.0%
Miscellaneous
4 companies
20.0%

Sean Wieland of Piper Sandler specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology and companies.

Coverage Industries

IndustryPercentage
MEDICAL INFO SYS
3 companies
15.0%
Miscellaneous
3 companies
15.0%
MEDICAL SERVICES
2 companies
10.0%
PREPACKAGED SOFTWARE
2 companies
10.0%
MED INSTRUMENTS
1 company
5.0%
OFFICES & CLINICS OF MEDICAL DOCTORS
1 company
5.0%
COMMUNICATION EQUIPMENT
1 company
5.0%
CUSTOM COMPUTER PROGRAMMING SERVICES
1 company
5.0%
DATA PROCESSING & PREPARATION
1 company
5.0%
MISCELLANEOUS HEALTH & ALLIED SERVICES
1 company
5.0%
INTERNET SOFTWARE
1 company
5.0%
HEALTH INFORMATION SERVICES
1 company
5.0%
COMPUTER INTEGRATED SYSTEMS DESIGN
1 company
5.0%
HOLDING & OTHER INVESTMENT OFFICES
1 company
5.0%

Sean Wieland's Ratings History at Piper Sandler

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Omnicell, Inc. stock logo
OMCL
Omnicell
8/11/2025Lower Price Target$30.83$55.00Overweight
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
8/11/2025Lower Price Target$20.58$35.00Overweight
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
2/28/2025Boost Price Target$25.46$40.00Overweight